$NUMIF News

Last published 2y ago

2y agoMBAIF NUMIFMedBright AI Announces Strategic Acquisition by Numinus WellnessGlobeNewswirePlans name change to "Numinus Intelligence" leveraging its current revenue generating operations to AI-enable mental health clinics across the US The strategic combination merges MedBright's AI-enabled clinical solution
2y agoNUMIFNuminus Wellness Inc. Announces $6 Million Bought Deal Public Offering with Leads Orders from MAPS and Integrated V.C.GlobeNewswireTHIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Feb. 01, 2024
3y agoNUMIFNuminus to Participate in a Water Tower Research Fireside Chat on Wednesday, June 7, 2023PR NewswireVANCOUVER, BC, June 2, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based
3y agoNUMIFNuminus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted TherapyPR NewswireFirst Numinus Network™ partner enters into agreementRecent cost containment initiatives have resulted in approximately $4.2 million of annualized savings, extending cash runway Well positioned to provide
3y agoNUMIFNuminus to Participate in a Water Tower Research Fireside Chat on Wednesday, April 19, 2023PR NewswireVANCOUVER, BC, April 17, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based
3y agoNUMIFNuminus Launches New Website to Enhance its Client ExperiencePR NewswireVANCOUVER, BC, April 14, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based
3y agoNUMIFNuminus Wellness Inc. Reports Q2 2023 ResultsPR NewswireQ2 2023 revenues grew 581.1% year-over-year to $5.4 millionQ2 2023 gross margin increased to 39.3% from 29.1% in Q2 2022Gross profit of $2.1 million, increased 820.9% year-over-yearStrong cash position of $19.7
3y agoNUMIFNuminus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate ExpansionPR NewswireLicensing model enables Numinus to scale with limited capital investment and overheadProvides practitioners with an alternate model, allowing them to retain ownership of their practice and performance while leveraging
3y agoNUMIFNuminus to Host Q2 2023 Results Conference Call on April 13, 2023PR NewswireVANCOUVER, BC, March 30, 2023 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based
3y agoNUMIFNuminus Launches the Practitioner Certification Pathway - a Complete Psychedelic-Assisted Therapy Training ProgramPR NewswireVANCOUVER, BC, March 27, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe,
3y agoNUMIFNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023PR NewswireVANCOUVER, BC, March 22, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe,
3y agoNUMIFNuminus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023PR NewswireVANCOUVER, BC, March 21, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe,
3y agoNUMIFNuminus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest ConferencePR NewswireCEO and founder, Payton Nyquvest, to be featured on panel titled "Music as Medicine: Music as a Tool For Healing" alongside Dr. Reid Robison, Charlotte James and East Forest VANCOUVER, BC, March 7, 2023
3y agoNUMIFNuminus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023PR NewswireVANCOUVER, BC, Feb. 24, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe,
3y agoNUMIFNuminus Expands Research Capabilities with new Phoenix Clinical Research SitePR NewswireThe Phoenix Site is Numinus' Third Research Facility in the US VANCOUVER, BC, Feb. 17, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTCQX:NUMIF), a mental health care company advancing
3y agoNUMIFNuminus Wellness Announces Voting Results From its Annual General and Special Meeting of ShareholdersPR NewswireVANCOUVER, BC, Feb. 15, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe,
3y agoNUMIFNuminus Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis TeaPR NewswireClinical trial will be the first to test whole Psilocybe mushrooms for safety and efficacy in a clinical setting; study is expected to provide important data to support increased access to psilocybin-assisted
3y agoNUMIFNuminus Wellness Inc. Reports Q1 2023 ResultsPR NewswireQ1 2023 revenues grew 618% year-over-year to $5.7 millionQ1 2023 gross margin grew to 41.9% from 31.5% in prior quarterGross profit of $2.4 million, an increase of $1.1 million from prior quarterEnded quarter with cash
3y agoNUMIFNuminus to Host Q1 2023 Results Conference Call on January 16, 2023PR NewswireVANCOUVER, BC, Jan. 4, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe,
3y agoNUMIFNuminus to Participate in the KCSA Mental Health Virtual Investor Conference on December 15, 2022PR NewswireVANCOUVER, BC, Dec. 12, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe,
3y agoNUMIFNuminus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training ResearchPR NewswireNew clinical trial will provide experiential training to therapists learning to conduct psilocybin-assisted therapy.Clinical trial dosing will use Numinus Bioscience's Psilocybin Tea, EnfiniTea – one of the first
3y agoNUMIFNuminus Wellness Inc. Reports Q4 2022 and Annual ResultsPR NewswireQ4 2022 revenues grew 643% year-over-year to $4.2 million Q4 2022 gross margin grew to 31.5%, generated $1.3 million of gross profitCompleted acquisition of Novamind, positioning Numinus as a leading, integrated mental
3y agoNUMIFNuminus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022PR NewswireVANCOUVER, BC, Nov. 22, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe,
3y agoNUMIFNuminus to Host Q4 and Year End 2022 Results Conference Call on November 29, 2022PR NewswireVANCOUVER, BC, Nov. 15, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based
4y agoNUMIFNuminus Re-Launches "Psychedelic Therapy Frontiers" Podcast with additional hosts and topicsPR NewswireSeries is Devoted to Exploring The Psychedelic Renaissance and Cultivating a Healthy Mind, Body and Spirit VANCOUVER, BC, Nov. 1, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company")
4y agoNUMIFNuminus to Participate in Wonderland: Miami on November 3-5, 2022PR NewswireVANCOUVER, BC, Oct. 31, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe,
4y agoNUMIFNuminus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical IllnessPR NewswireClinical program broadens access to ketamine-assisted therapy for an underserved population VANCOUVER, BC, Oct. 28, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI)
4y agoNUMIFNuminus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022PR NewswireVANCOUVER, BC, Oct. 7, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based
4y agoACHC DRUG HCA LFST+1New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death ExperiencesPR NewswireFN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Oct. 5, 2022 /PRNewswire/ -- A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational
4y agoNUMIFNuminus Develops Mushroom Tea for Use in Psychedelic ResearchPR NewswirePsilocybin-containing tea bag offers substitute for whole mushrooms and other solid therapeutics VANCOUVER, B.C, Oct. 5, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advan
4y agoNUMIFNuminus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022PR NewswireVANCOUVER, BC, Sept. 29, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announ
4y agoACHC HCA LFST NUMIF+1Mental Health Claims up 75% Since 2019PR NewswireFN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Sept. 23, 2022 /PRNewswire/ -- Canadian health insurers processed nearly $600 million in mental health service claims in 2021, up 75% from 2019 as more Canadians tapped into their
4y agoATAI CMPS CYBN MNMD+1Atlanta Becomes Latest City to Consider Decriminalizing PsychedelicsPR NewswireFN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Sept. 22, 2022 /PRNewswire/ -- Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminali
4y agoNUMIFNuminus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiativesPR NewswireNew Montreal space will focus on treating depression, addiction and other common disorders Numinus announces sponsorship of East Forest North American tour Company also announces new PR and Marketing partners VANCOUVER, BC, Sept. 22, 2022 /PRNewswir
4y agoNUMIFNuminus Now Offers Ketamine-Assisted Therapy in TorontoPR NewswireTreatment will be offered at the Neurology Centre of Toronto in Forest Hill VANCOUVER, BC, Sept. 19, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative trea
4y agoNUMIFNuminus provides update on acquisition integration and announces new client financing optionsPR NewswireUS clinics acquired from Novamind demonstrating continued growth Physical rebranding of clinics is underway Announcing new client financing options in Canada VANCOUVER, BC, Sept. 13, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus", the "Company
4y agoATAI NUMIF OPTHF SEEL+1Psychedelics Use Among Young Adults Reaches All-Time HighPR NewswireFN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Sept. 1, 2022 /PRNewswire/ -- Young adults are using more hallucinogens than ever. According to a National Institute of Health survey, the amount of people between age 19 to 30 who
4y agoNUMIFNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PR NewswireVANCOUVER, BC, Aug. 31, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announc
4y agoNUMIFNuminus Wellness Inc. Reports Q3 2022 ResultsPR NewswireRevenues grew 32% year-over-year to $0.74 million for the quarter Clinic network revenues grew 59.5% from the same quarter last year and 7.5% compared to prior quarter Achieved 24.4% gross margin and $180,845 gross profit of during Q3 2022 Ended qu
4y agoNUMIFNuminus to Host Q3 2022 Results Conference Call on July 14, 2022PR NewswireVANCOUVER, BC, July 6, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, will release its
4y agoNUMIFNuminus Unveils New Logo and Brand IdentityPR NewswireNew branding unifies Numinus' presence across North America Rebranding will be accomplished in phases and completed by end of 2022 VANCOUVER, BC, June 27, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus", the "Company") (TSX:NUMI) (OTCQX:NUMIF)
4y agoNUMIFNuminus Pilots Mental Health Program for Corporate Clients in UtahPR NewswireVANCOUVER, BC, June 23, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus", the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to ann
4y agoNUMIFNuminus Applies for International Patent Filing of Psychedelics Production ProcessPR NewswireFiling would offer added protection to IP already submitted to USPTO VANCOUVER, BC, June 22, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments a
4y agoCMPS CYBN MNMD NUMIF+1World's Richest Man Says Psychedelics Could Make a Real Difference in Mental HealthPR NewswireFN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, June 15, 2022 /PRNewswire/ -- Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a number of mental health conditions. The Tesl
4y agoNUMIF NVMDFNovamind Obtains Final Order for Plan of Arrangement from the Supreme Court of British Columbia and Completes Acquisition by Numinus Wellness Inc.ACCESS NewswireTORONTO, ON / ACCESSWIRE / June 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that the Company has completed its previously anno
4y agoNUMIFNuminus completes acquisition of Novamind and announces executive appointmentsPR NewswireTransaction has completed following shareholder and court approvals Novamind shareholders and RSU holders have been issued 0.84 Numinus shares per Novamind share As a result of the acquisition, Novamind has ceased trading on the Canadian Securities Ex
4y agoNUMIFNuminus announces shareholder approval of resolution in connection with the proposed acquisition of NovamindPR NewswireNovamind shareholders, at a separate meeting held today, have also approved the transaction Transaction expected to be completed on or about June 10, 2022 VANCOUVER, BC, June 8, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus", the "Company") (TS
4y agoNUMIFNuminus announces ISS recommends shareholders vote in favor of the share issuance to acquire NovamindPR NewswireISS states that the proposed acquisition is in the best interest of Numinus shareholders Shareholders are encouraged to vote their common shares prior to the proxy deadline of June 6, 2022 at 11:00 a.m. PT. For any questions on voting, please contact
4y agoNUMIFNuminus Mails Materials for Special Meeting of Shareholders and Announces Interim Court Order for Plan of ArrangementPR NewswireShareholders are encouraged to vote their common shares prior to the proxy deadline of June 6, 2022 at 11:00 a.m. PT VANCOUVER, BC, May 10, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus", the "Company") (TSX:NUMI) (OTCQX:NUMIF) today announces th
4y agoNUMIFNuminus to Participate in Upcoming Research & Industry ConferencesPR NewswireNuminus leaders will speak at Catalyst, Psychedelic Therapeutics & From Research to Reality VANCOUVER, BC , May 9, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX:NUMI) (OTCQX:NUMIF), a mental healthcare company advancing innovati